1APF image
Deposition Date 1995-05-30
Release Date 1996-07-11
Last Version Date 2024-10-23
Entry Detail
PDB ID:
1APF
Title:
ANTHOPLEURIN-B, NMR, 20 STRUCTURES
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Conformers Submitted:
20
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:ANTHOPLEURIN-B
Chain IDs:A
Chain Length:49
Number of Molecules:1
Biological Source:Anthopleura xanthogrammica
Ligand Molecules
Primary Citation
Solution structure of the cardiostimulant polypeptide anthopleurin-B and comparison with anthopleurin-A.
Structure 3 791 803 (1995)
PMID: 7582896 DOI: 10.1016/S0969-2126(01)00214-3

Abstact

BACKGROUND The polypeptide anthopleurin-B (AP-B) is one of a number of related toxins produced by sea anemones. AP-B delays inactivation of the voltage-gated sodium channel of excitable tissue. In the mammalian heart, this effect is manifest as an increase in the force of contraction. As a result, there is interest in exploiting the anthopleurins as lead compounds in the design of novel cardiac stimulants. Essential to this endeavour is a high-resolution solution structure of the molecule describing the positions of functionally important side chains. RESULTS AP-B exists in multiple conformations in solution as a result of cis-trans isomerization about the Gly40-Pro41 peptide bond. The solution structure of the major conformer of AP-B has been determined by two-dimensional 1H NMR at pH 4.5 and 25 degrees C. The core structure is a four-stranded, antiparallel beta-sheet (residues 2-4, 20-23, 34-37 and 45-48) and includes several beta-turns (6-9, 25-28, 30-33). Three loops connect the beta-strands, the longest and least well defined being the first loop, extending from residues 8-17. These features are shared by other members of this family of sea anemone toxins. The locations of a number of side chains which are important for the cardiac stimulatory activity of AP-B are well defined in the structures. CONCLUSIONS We have described the solution structure of AP-B and compared it with that of AP-A, from which it differs by substitutions at seven amino acid positions. It shares an essentially identical fold with AP-A yet is about 10-fold more active. Comparison of the structures, particularly in the region of residues essential for activity, gives a clearer indication of the location and extent of the cardioactive pharmacophore in these polypeptides.

Legend

Protein

Chemical

Disease

Primary Citation of related structures